Search Result "anaplastic lymphoma kinase."

Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 3 Year: 2010 Page: 236-249
Author(s): Mangeng Cheng, Gregory R. Ott

Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer

Journal: Current Drug Targets
Volume: 17 Issue: 6 Year: 2016 Page: 739-745
Author(s): David M. Straughan, Sa d C. Azoury, Vivek Shukla

Review Article

Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13 Issue: 2 Year: 2018 Page: 209-223
Author(s): Theodosis Kalamatianos,Despoina Denekou,George Stranjalis,Evangelia Papadimitriou

Research Article

Prospecting for New Inhibitors of Anaplastic Lymphoma Kinase, A Clinically Relevant Oncogenic Drug Target

Journal: Current Bioactive Compounds
Volume: 13 Issue: 3 Year: 2017 Page: 236-243
Author(s): Daniel F. Kawano, Carlton A. Taft, Carlos H.T.P. da Silva

Review Article

Recent Development in the Discovery of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Non-small Cell Lung Cancer

Journal: Current Medicinal Chemistry
Volume: 24 Issue: 6 Year: 2017 Page: 590-613
Author(s): Jingru Liu,Shutao Ma

Research Article

Identification of Novel Structurally Diverse Anaplastic Lymphoma Kinase Inhibitors Based on Pharmacophore Modeling, Virtual Screening and Molecular Docking

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 19 Issue: 9 Year: 2016 Page: 691-704
Author(s): Rong You, Lu Zhou, Liangliang Zhong, Xiaoli Li, Suwen Zhou, Yahui Tian

Research Article

Molecular Docking, 3D-QSAR, Fingerprint-Based 2D-QSAR, Analysis of Pyrimidine, and Analogs of ALK (Anaplastic Lymphoma Kinase) Inhibitors as an Anticancer Agent

Journal: Letters in Drug Design & Discovery
Volume: 18 Issue: 5 Year: 2021 Page: 509-521
Author(s): Vivek Yadav,Rajiv Kumar Tonk,Ramchander Khatri

Review Article

Research Progress on the Drug Resistance of ALK kinase Inhibitors

Journal: Current Medicinal Chemistry
Volume: 28 Issue: 0 Year: 2021 Page: 1-20
Author(s): Zhen Li,Fang Liu,Shuang Wu,Shi Ding,Ye Chen,Ju Liu

Clinical Development of mTOR Inhibitors: A Focus on Lymphoma

Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 2 Year: 2007 Page: 103-110
Author(s): Sonali M. Smith

Oncogenic MicroRNAs in the Genesis of Leukemia and Lymphoma

Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 5260-5267
Author(s): Yanyan Pan, Mei Meng, Gaochuan Zhang, Hongyan Han, Quansheng Zhou

Previous   Next

Go To   Results 1 - 1 of 598

Filter Result

Volume Year
© 2022 Bentham Science Publishers | Privacy Policy